Valuation: Kwality Pharmaceuticals Limited

Market Cap 3.48TCr 36Cr 31Cr 29Cr 27Cr 50Cr 51Cr 344.76Cr 134.44Cr 1.75TCr 136.7Cr 133.73Cr 5.79TCr P/E 2025
22.6x
P/E 2026 20.1x
Enterprise Value 3.61TCr 38Cr 32Cr 30Cr 28Cr 52Cr 53Cr 357.34Cr 139.35Cr 1.81TCr 141.69Cr 138.61Cr 6TCr EV / Sales 2025
2.7x
EV / Sales 2026 2.95x
Free-Float
22.51%
Yield 2025 *
-
Yield 2026 -
10/08 Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
02/06 Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026 CI
19/05 Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9% MT
19/05 Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 CI
19/05 Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/03 Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026 CI
10/03 Kwality Pharmaceuticals completes phase 1 BE studies for three molecules RE
12/02 Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16% MT
12/02 Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees RE
12/02 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02/02 Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026 CI
13/11 Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
13/11 Kwality Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q2; Shares Up 7% MT
1 day-7.45%
1 week-2.54%
Current month+29.82%
1 month+24.47%
3 months+57.23%
6 months+135.64%
Current year+202.89%
1 week 3,328.5
Extreme 3328.5
3,725.45
1 month 2,476
Extreme 2476
3,725.45
Current year 1,020
Extreme 1020
3,725.45
1 year 828.8
Extreme 828.8
3,725.45
3 years 308.7
Extreme 308.7
3,725.45
5 years 248
Extreme 248
3,725.45
10 years 21.3
Extreme 21.3
3,725.45
Manager TitleAgeSince
Chief Executive Officer 72 04/05/1983
Director of Finance/CFO 32 22/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 72 04/05/1983
Director/Board Member 58 01/08/1995
Director/Board Member 64 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
-7.45%-2.54%+231.48%+788.36% 36Cr
+0.88%+6.38%+76.40%+126.75% 1,11900Cr
+1.07%+3.80%+50.73%+62.78% 65TCr
+1.20%+6.21%+25.81%+78.74% 47TCr
+1.02%+5.77%+43.63%+48.43% 37TCr
+0.85%+4.07%+24.97%+40.58% 30TCr
+1.26%+6.81%+2.27%+14.41% 26TCr
+1.88%+5.81%+49.57%+70.53% 24TCr
+1.59%+2.09%-17.33%-52.62% 21TCr
+1.87%+5.61%+27.32%+91.38% 18TCr
Average +0.42%+4.22%+51.49%+126.93% 38TCr
Weighted average by Cap. +1.14%+5.09%+44.28%+72.72%

Financials

2025 2026
Net sales 370.2Cr 3.87Cr 3.31Cr 3.1Cr 2.84Cr 5.33Cr 5.4Cr 37Cr 14Cr 185.97Cr 15Cr 14Cr 615.1Cr 503.08Cr 5.26Cr 4.5Cr 4.21Cr 3.86Cr 7.24Cr 7.34Cr 50Cr 19Cr 252.72Cr 20Cr 19Cr 835.9Cr
Net income 40Cr 41.64L 35.67L 33.38L 30.55L 57.34L 58.1L 3.94Cr 1.54Cr 20Cr 1.56Cr 1.53Cr 66Cr 67Cr 70.39L 60.29L 56.42L 51.64L 96.92L 98.2L 6.67Cr 2.6Cr 34Cr 2.64Cr 2.59Cr 111.9Cr
Net Debt 98Cr 1.02Cr 87.46L 81.83L 74.91L 1.41Cr 1.42Cr 9.67Cr 3.77Cr 49Cr 3.83Cr 3.75Cr 162.32Cr 127.11Cr 1.33Cr 1.14Cr 1.06Cr 97.47L 1.83Cr 1.85Cr 13Cr 4.91Cr 64Cr 4.99Cr 4.88Cr 211.21Cr
Logo Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Employees
1,137
Date Price Change Volume
21/26/21 ₹3,357.10 -7.45% 20,376
20/26/20 ₹3,627.25 +5.06% 15,337
19/26/19 ₹3,452.60 -2.17% 3,147
18/26/18 ₹3,529.15 -1.72% 5,650
17/26/17 ₹3,590.75 +4.24% 15,670

Annual profits - Rate of surprise